164
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Photochemical degradation of dexamethasone by UV/Persulphate, UV/Hydrogen peroxide and UV/free chlorine processes in aqueous solution using response surface methodology (RSM)

, &
Pages 2056-2074 | Received 09 Dec 2021, Accepted 24 Feb 2022, Published online: 20 Apr 2022
 

ABSTRACT

Dexamethasone (DEX) degradation was investigated using three UV-based advanced oxidation processes combined with sodium persulphate, hydrogen peroxide, and free chlorine in aqueous solutions in a bench-scale reactor. The goal was to determine which process would be the best option in terms of DEX degradation without the subsequent generation of toxic compounds. The process performance for DEX degradation followed the UV/S2O82−> UV/H2O2> UV/HOCl order under equal conditions. In the UV/S2O82− process, sulphate radicals led to a 70.4% DEX degradation. The experimental mineral inhibitory factors showed that nitrite and bicarbonate further decrease the efficiency of the UV/S2O82− process. In the optimal conditions, the UV/S2O8−2 process removed DEX by 100% and had a 74.1% mineralisation. Furthermore, the intermediates were detected using LC-MS/MS, and the cytotoxicity of the UV/S2O8−2 process effluent was evaluated using human embryonic kidney cultured cells. The treatment of DEX solution by the UV/S2O8−2 process significantly decreased the toxicity of the effluent. Therefore, it can be concluded that the UV/S2O8−2 process can be a reliable process for DEX degradation and detoxification in aqueous solutions.

Acknowledgments

The authors of this article sincerely express their gratitude to all those who have cooperated and assisted in the implementation of this research in any way.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Supplementary material

Supplemental data for this article can be accessed here.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.